AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇳🇬
Erenumab in Nigeria
2 products registered with NAFDAC — 2 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Pasurta 140 mg/mL Solution for Injection in a Prefilled Syringe** Solution for injection | A6-100009 | Novartis Nigeria Limited | active | 6 May 2026 |
| Pasurta 70 mg/mL Solution for Injection in a Prefilled Syringe** Solution for injection | A6-100008 | Novartis Nigeria Limited | active | 6 May 2026 |
Erenumab — NAFDAC Registration Details
NAFDAC (Nigeria) has 2 registered products containing Erenumab, of which 2 are currently active. Data is sourced directly from the official NAFDAC drug register and refreshed daily.
Track Erenumab registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.